journal article Feb 06, 2020

Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals

British Journal of Pharmacology Vol. 177 No. 6 pp. 1227-1240 · Wiley
View at Publisher Save 10.1111/bph.14943
Abstract
The nutraceuticals market is vast, encompassing many different products with inconsistent levels of evidence available to support their use. This overview represents a Western perspective of the nutraceuticals market, with a brief comparison with that in China, as an illustration of how individual health supplements increase and decrease in popularity in regional terms. Recent changes in sales patterns, mainly taken from the US market, are summarized and a selection of five newer products, which have not been subject to extensive recent review are profiled: astaxanthin, a carotenoid found in red algae, seafood, salmon and trout, as an antioxidant; cannabidiol, a non‐euphoric marijuana ingredient used as mood enhancer and for painful/inflammatory conditions; modified extracts of ginseng used in new indications including dementia and space travel; monk fruit, a non‐sugar high intensity sweetener and nigella seed, a popular food ingredient and Asian medicine, which has experienced an extraordinary rise in sales recently.Linked ArticlesThis article is part of a themed section on The Pharmacology of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.6/issuetoc
Topics

No keywords indexed for this article. Browse by subject →

References
113
[4]
Alexander S. P. H. "CGTP Collaborators. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction andOther Protein Targets" Br J Pharmacol (2019)
[15]
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent

Mateus Machado Bergamaschi, Regina Helena Costa Queiroz, Antonio Waldo Zuardi et al.

Current Drug Safety 10.2174/157488611798280924
[21]
BuserS SchierleJ SchüepWet al(2003).Ro 11e3741/021 (Astaxanthin): 104‐week oral carcinogenicity study in the Rat. Protocol No. 002V92 12‐May‐2003 DSM Report 1007905 10.1088/1126-6708/2003/12/021
[25]
Dang H. (2014)
[29]
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Orrin Devinsky, J. Helen Cross, Linda Laux et al.

New England Journal of Medicine 10.1056/nejmoa1611618
[33]
Engels G. "Nigella. (Nigella sativa, Ranunculaceae)" HerbalGram (2017)
[35]
Geng J. "Ginseng for cognition" Cochrane Database of Systematic Reviews (2010)
[36]
Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review

Zahra Gholamnezhad, Shahrzad Havakhah, Mohammad Hossein Boskabady

Journal of Ethnopharmacology 10.1016/j.jep.2016.06.061
[38]
Grandview research(2019).β‐glucan market analysis by source (cereal mushroom yeasts seaweed) by application (F&B Personal Care Pharmaceuticals Animal Feed) By Type By Region And Segment Forecasts 2018–2025:https://www.grandviewresearch.com/industry-analysis/beta-glucan-market. Accessed May 2019
[44]
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

Simon D Harding, Joanna L Sharman, Elena Faccenda et al.

Nucleic Acids Research 10.1093/nar/gkx1121
[46]
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies

Kerstin Iffland, Franjo Grotenhermen

Cannabis & Cannabinoid Research 10.1089/can.2016.0034
[49]
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

Angelo A. Izzo, Francesca Borrelli, Raffaele Capasso et al.

Trends in Pharmacological Sciences 10.1016/j.tips.2009.07.006

Showing 50 of 113 references

Metrics
277
Citations
113
References
Details
Published
Feb 06, 2020
Vol/Issue
177(6)
Pages
1227-1240
License
View
Cite This Article
Elizabeth M. Williamson, Xinmin Liu, Angelo A. Izzo (2020). Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals. British Journal of Pharmacology, 177(6), 1227-1240. https://doi.org/10.1111/bph.14943
Related

You May Also Like